✦ LIBER ✦

P-739 Prospective multicenter safety study of subcutaneous amifostinefor non-small cell lung cancer: Preliminary findings

✍ Scribed by Samuels, M.; Fullmer, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of routine invasive staging for

✍ Celik, M; Kiyik, M; Gurses, A; Kir, A; Kiliçaslan, Z; Arman, B; Cikrikcioglu, S; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 119 KB

PCN25 Utility of Advanced Non-Small Cell

✍ Tongpak, P.; Thongprasert, S.; Permsuwan, U. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Assessment of palliative care for advanc

✍ Vergnenègre, Alain; Hominal, Stéphane; Tchalla, Achille Edem; Bérard, Henri; Mon 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 494 KB

O-87 Duration of chemotherapy and surviv

✍ Andresen, Olga; Sörenson, Sverre; Bergman, Bengt; Sundstrøm, Stein; Vilsvik, Jan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 355 KB

Gemcitabine versus gemcitabine/carboplat

✍ Christer Sederholm 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 125 KB

p53 Mutations and Survival in Stage I No

✍ Ahrendt, S. A.; Hu, Y.; Buta, M.; McDermott, M. P.; Benoit, N.; Yang, S. C.; Wu, 📂 Article 📅 2003 🏛 Oxford University Press 🌐 English ⚖ 433 KB